Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First Zika Microcephaly birth reported in Europe 
Pregnant
Medics delivered the baby by Caesarean section and say the mother has developed 'no complications'.

Baby reported as 'clinically stable'

A Spanish hospital has reported Europe's first known case of Zika-related Microcephaly.

In a statement, Vall d'Hebron University Hospital, Barcelona, announced that a woman gave birth on Sunday (24 July) to a baby with the disease.

Felix Castillo, head of Vall d'Hebron's Neonatal Hospital, explained that while the baby's head is smaller than normal, the child is 'clinically stable' and 'has normal vital signs'.
He added that the baby is being monitored but doesn't need any respiratory assistance.

Medics delivered the baby by Caesarean section and say the mother has developed 'no complications' and is 'recovering well'. Some media reports suggest the mother contracted Zika after time spent travelling in South America, although this has not been confirmed.

Zika is spread mostly by the bite of an infected Aedes species mosquito and can be passed from a pregnant woman to her fetus.
While the virus has been linked to hundreds of cases of Microcephaly in Latin America, this is believed to be the first in Europe.

A pregnant woman in Slovenia who had contracted Zika virus discovered that she was carrying a baby with Microcephaly, but she decided to terminate the pregnancy.

Babies born with the disease often have smaller brains and can suffer developmental delay, seizures and hearing loss, amongst other problems.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.